世界の多系統萎縮症治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Multiple System Atrophy Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4535 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、多系統萎縮症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アンレ-138b、AZD-3241、CS-10BR05、NPT-20011、PBT-434、PD-01）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・多系統萎縮症治療薬の市場動向 ・企業の競争状況、市場シェア ・多系統萎縮症治療薬の種類別市場規模と予測2016-2027（アンレ-138b、AZD-3241、CS-10BR05、NPT-20011、PBT-434、PD-01） ・多系統萎縮症治療薬の用途別市場規模と予測2016-2027（病院、クリニック、その他） ・多系統萎縮症治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・多系統萎縮症治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・多系統萎縮症治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・多系統萎縮症治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・多系統萎縮症治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AFFiRiS AG、AstraZeneca Plc、Corestem Inc、MitoDys Therapeutics Ltd、Modag GmbH、Neuropore Therapies Inc、Prana Biotechnology Ltd） ・結論

Market Analysis and Insights: Global Multiple System Atrophy Therapeutics Market
The global Multiple System Atrophy Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Multiple System Atrophy Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Multiple System Atrophy Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Multiple System Atrophy Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Multiple System Atrophy Therapeutics market.

Global Multiple System Atrophy Therapeutics Scope and Market Size
Multiple System Atrophy Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Multiple System Atrophy Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Anle-138b
AZD-3241
CS-10BR05
NPT-20011
PBT-434
PD-01

Segment by Application
Hospital
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AFFiRiS AG
AstraZeneca Plc
Corestem Inc
MitoDys Therapeutics Ltd
Modag GmbH
Neuropore Therapies Inc
Prana Biotechnology Ltd

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Multiple System Atrophy Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Anle-138b
1.2.3 AZD-3241
1.2.4 CS-10BR05
1.2.5 NPT-20011
1.2.6 PBT-434
1.2.7 PD-01
1.3 Market by Application
1.3.1 Global Multiple System Atrophy Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Multiple System Atrophy Therapeutics Market Perspective (2016-2027)
2.2 Multiple System Atrophy Therapeutics Growth Trends by Regions
2.2.1 Multiple System Atrophy Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Multiple System Atrophy Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Multiple System Atrophy Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Multiple System Atrophy Therapeutics Industry Dynamic
2.3.1 Multiple System Atrophy Therapeutics Market Trends
2.3.2 Multiple System Atrophy Therapeutics Market Drivers
2.3.3 Multiple System Atrophy Therapeutics Market Challenges
2.3.4 Multiple System Atrophy Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Multiple System Atrophy Therapeutics Players by Revenue
3.1.1 Global Top Multiple System Atrophy Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Multiple System Atrophy Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Multiple System Atrophy Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Multiple System Atrophy Therapeutics Revenue
3.4 Global Multiple System Atrophy Therapeutics Market Concentration Ratio
3.4.1 Global Multiple System Atrophy Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multiple System Atrophy Therapeutics Revenue in 2020
3.5 Multiple System Atrophy Therapeutics Key Players Head office and Area Served
3.6 Key Players Multiple System Atrophy Therapeutics Product Solution and Service
3.7 Date of Enter into Multiple System Atrophy Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Multiple System Atrophy Therapeutics Breakdown Data by Type
4.1 Global Multiple System Atrophy Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Multiple System Atrophy Therapeutics Forecasted Market Size by Type (2022-2027)

5 Multiple System Atrophy Therapeutics Breakdown Data by Application
5.1 Global Multiple System Atrophy Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Multiple System Atrophy Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Multiple System Atrophy Therapeutics Market Size (2016-2027)
6.2 North America Multiple System Atrophy Therapeutics Market Size by Type
6.2.1 North America Multiple System Atrophy Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Multiple System Atrophy Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Multiple System Atrophy Therapeutics Market Size by Type (2016-2027)
6.3 North America Multiple System Atrophy Therapeutics Market Size by Application
6.3.1 North America Multiple System Atrophy Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Multiple System Atrophy Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Multiple System Atrophy Therapeutics Market Size by Application (2016-2027)
6.4 North America Multiple System Atrophy Therapeutics Market Size by Country
6.4.1 North America Multiple System Atrophy Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Multiple System Atrophy Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Multiple System Atrophy Therapeutics Market Size (2016-2027)
7.2 Europe Multiple System Atrophy Therapeutics Market Size by Type
7.2.1 Europe Multiple System Atrophy Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Multiple System Atrophy Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Multiple System Atrophy Therapeutics Market Size by Type (2016-2027)
7.3 Europe Multiple System Atrophy Therapeutics Market Size by Application
7.3.1 Europe Multiple System Atrophy Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Multiple System Atrophy Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Multiple System Atrophy Therapeutics Market Size by Application (2016-2027)
7.4 Europe Multiple System Atrophy Therapeutics Market Size by Country
7.4.1 Europe Multiple System Atrophy Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Multiple System Atrophy Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Multiple System Atrophy Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Multiple System Atrophy Therapeutics Market Size by Type
8.2.1 Asia-Pacific Multiple System Atrophy Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Multiple System Atrophy Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Multiple System Atrophy Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Multiple System Atrophy Therapeutics Market Size by Application
8.3.1 Asia-Pacific Multiple System Atrophy Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Multiple System Atrophy Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Multiple System Atrophy Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Multiple System Atrophy Therapeutics Market Size by Region
8.4.1 Asia-Pacific Multiple System Atrophy Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Multiple System Atrophy Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Multiple System Atrophy Therapeutics Market Size (2016-2027)
9.2 Latin America Multiple System Atrophy Therapeutics Market Size by Type
9.2.1 Latin America Multiple System Atrophy Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Multiple System Atrophy Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Multiple System Atrophy Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Multiple System Atrophy Therapeutics Market Size by Application
9.3.1 Latin America Multiple System Atrophy Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Multiple System Atrophy Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Multiple System Atrophy Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Multiple System Atrophy Therapeutics Market Size by Country
9.4.1 Latin America Multiple System Atrophy Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Multiple System Atrophy Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Multiple System Atrophy Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Multiple System Atrophy Therapeutics Market Size by Type
10.2.1 Middle East & Africa Multiple System Atrophy Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Multiple System Atrophy Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Multiple System Atrophy Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Multiple System Atrophy Therapeutics Market Size by Application
10.3.1 Middle East & Africa Multiple System Atrophy Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Multiple System Atrophy Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Multiple System Atrophy Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Multiple System Atrophy Therapeutics Market Size by Country
10.4.1 Middle East & Africa Multiple System Atrophy Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Multiple System Atrophy Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AFFiRiS AG
11.1.1 AFFiRiS AG Company Details
11.1.2 AFFiRiS AG Business Overview
11.1.3 AFFiRiS AG Multiple System Atrophy Therapeutics Introduction
11.1.4 AFFiRiS AG Revenue in Multiple System Atrophy Therapeutics Business (2016-2021)
11.1.5 AFFiRiS AG Recent Development
11.2 AstraZeneca Plc
11.2.1 AstraZeneca Plc Company Details
11.2.2 AstraZeneca Plc Business Overview
11.2.3 AstraZeneca Plc Multiple System Atrophy Therapeutics Introduction
11.2.4 AstraZeneca Plc Revenue in Multiple System Atrophy Therapeutics Business (2016-2021)
11.2.5 AstraZeneca Plc Recent Development
11.3 Corestem Inc
11.3.1 Corestem Inc Company Details
11.3.2 Corestem Inc Business Overview
11.3.3 Corestem Inc Multiple System Atrophy Therapeutics Introduction
11.3.4 Corestem Inc Revenue in Multiple System Atrophy Therapeutics Business (2016-2021)
11.3.5 Corestem Inc Recent Development
11.4 MitoDys Therapeutics Ltd
11.4.1 MitoDys Therapeutics Ltd Company Details
11.4.2 MitoDys Therapeutics Ltd Business Overview
11.4.3 MitoDys Therapeutics Ltd Multiple System Atrophy Therapeutics Introduction
11.4.4 MitoDys Therapeutics Ltd Revenue in Multiple System Atrophy Therapeutics Business (2016-2021)
11.4.5 MitoDys Therapeutics Ltd Recent Development
11.5 Modag GmbH
11.5.1 Modag GmbH Company Details
11.5.2 Modag GmbH Business Overview
11.5.3 Modag GmbH Multiple System Atrophy Therapeutics Introduction
11.5.4 Modag GmbH Revenue in Multiple System Atrophy Therapeutics Business (2016-2021)
11.5.5 Modag GmbH Recent Development
11.6 Neuropore Therapies Inc
11.6.1 Neuropore Therapies Inc Company Details
11.6.2 Neuropore Therapies Inc Business Overview
11.6.3 Neuropore Therapies Inc Multiple System Atrophy Therapeutics Introduction
11.6.4 Neuropore Therapies Inc Revenue in Multiple System Atrophy Therapeutics Business (2016-2021)
11.6.5 Neuropore Therapies Inc Recent Development
11.7 Prana Biotechnology Ltd
11.7.1 Prana Biotechnology Ltd Company Details
11.7.2 Prana Biotechnology Ltd Business Overview
11.7.3 Prana Biotechnology Ltd Multiple System Atrophy Therapeutics Introduction
11.7.4 Prana Biotechnology Ltd Revenue in Multiple System Atrophy Therapeutics Business (2016-2021)
11.7.5 Prana Biotechnology Ltd Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Multiple System Atrophy Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Anle-138b
Table 3. Key Players of AZD-3241
Table 4. Key Players of CS-10BR05
Table 5. Key Players of NPT-20011
Table 6. Key Players of PBT-434
Table 7. Key Players of PD-01
Table 8. Global Multiple System Atrophy Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Multiple System Atrophy Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Multiple System Atrophy Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Multiple System Atrophy Therapeutics Market Share by Regions (2016-2021)
Table 12. Global Multiple System Atrophy Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Multiple System Atrophy Therapeutics Market Share by Regions (2022-2027)
Table 14. Multiple System Atrophy Therapeutics Market Trends
Table 15. Multiple System Atrophy Therapeutics Market Drivers
Table 16. Multiple System Atrophy Therapeutics Market Challenges
Table 17. Multiple System Atrophy Therapeutics Market Restraints
Table 18. Global Multiple System Atrophy Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Multiple System Atrophy Therapeutics Market Share by Players (2016-2021)
Table 20. Global Top Multiple System Atrophy Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Multiple System Atrophy Therapeutics as of 2020)
Table 21. Ranking of Global Top Multiple System Atrophy Therapeutics Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Multiple System Atrophy Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Multiple System Atrophy Therapeutics Product Solution and Service
Table 25. Date of Enter into Multiple System Atrophy Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Multiple System Atrophy Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Multiple System Atrophy Therapeutics Revenue Market Share by Type (2016-2021)
Table 29. Global Multiple System Atrophy Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Multiple System Atrophy Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Multiple System Atrophy Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Multiple System Atrophy Therapeutics Revenue Market Share by Application (2016-2021)
Table 33. Global Multiple System Atrophy Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Multiple System Atrophy Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Multiple System Atrophy Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Multiple System Atrophy Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Multiple System Atrophy Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Multiple System Atrophy Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Multiple System Atrophy Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Multiple System Atrophy Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Multiple System Atrophy Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Multiple System Atrophy Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Multiple System Atrophy Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Multiple System Atrophy Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Multiple System Atrophy Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Multiple System Atrophy Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Multiple System Atrophy Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Multiple System Atrophy Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Multiple System Atrophy Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Multiple System Atrophy Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Multiple System Atrophy Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Multiple System Atrophy Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Multiple System Atrophy Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Multiple System Atrophy Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Multiple System Atrophy Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Multiple System Atrophy Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Multiple System Atrophy Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Multiple System Atrophy Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Multiple System Atrophy Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Multiple System Atrophy Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Multiple System Atrophy Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Multiple System Atrophy Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Multiple System Atrophy Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Multiple System Atrophy Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 65. AFFiRiS AG Company Details
Table 66. AFFiRiS AG Business Overview
Table 67. AFFiRiS AG Multiple System Atrophy Therapeutics Product
Table 68. AFFiRiS AG Revenue in Multiple System Atrophy Therapeutics Business (2016-2021) & (US$ Million)
Table 69. AFFiRiS AG Recent Development
Table 70. AstraZeneca Plc Company Details
Table 71. AstraZeneca Plc Business Overview
Table 72. AstraZeneca Plc Multiple System Atrophy Therapeutics Product
Table 73. AstraZeneca Plc Revenue in Multiple System Atrophy Therapeutics Business (2016-2021) & (US$ Million)
Table 74. AstraZeneca Plc Recent Development
Table 75. Corestem Inc Company Details
Table 76. Corestem Inc Business Overview
Table 77. Corestem Inc Multiple System Atrophy Therapeutics Product
Table 78. Corestem Inc Revenue in Multiple System Atrophy Therapeutics Business (2016-2021) & (US$ Million)
Table 79. Corestem Inc Recent Development
Table 80. MitoDys Therapeutics Ltd Company Details
Table 81. MitoDys Therapeutics Ltd Business Overview
Table 82. MitoDys Therapeutics Ltd Multiple System Atrophy Therapeutics Product
Table 83. MitoDys Therapeutics Ltd Revenue in Multiple System Atrophy Therapeutics Business (2016-2021) & (US$ Million)
Table 84. MitoDys Therapeutics Ltd Recent Development
Table 85. Modag GmbH Company Details
Table 86. Modag GmbH Business Overview
Table 87. Modag GmbH Multiple System Atrophy Therapeutics Product
Table 88. Modag GmbH Revenue in Multiple System Atrophy Therapeutics Business (2016-2021) & (US$ Million)
Table 89. Modag GmbH Recent Development
Table 90. Neuropore Therapies Inc Company Details
Table 91. Neuropore Therapies Inc Business Overview
Table 92. Neuropore Therapies Inc Multiple System Atrophy Therapeutics Product
Table 93. Neuropore Therapies Inc Revenue in Multiple System Atrophy Therapeutics Business (2016-2021) & (US$ Million)
Table 94. Neuropore Therapies Inc Recent Development
Table 95. Prana Biotechnology Ltd Company Details
Table 96. Prana Biotechnology Ltd Business Overview
Table 97. Prana Biotechnology Ltd Multiple System Atrophy Therapeutics Product
Table 98. Prana Biotechnology Ltd Revenue in Multiple System Atrophy Therapeutics Business (2016-2021) & (US$ Million)
Table 99. Prana Biotechnology Ltd Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Multiple System Atrophy Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Anle-138b Features
Figure 3. AZD-3241 Features
Figure 4. CS-10BR05 Features
Figure 5. NPT-20011 Features
Figure 6. PBT-434 Features
Figure 7. PD-01 Features
Figure 8. Global Multiple System Atrophy Therapeutics Market Share by Application: 2020 VS 2027
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Others Case Studies
Figure 12. Multiple System Atrophy Therapeutics Report Years Considered
Figure 13. Global Multiple System Atrophy Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Multiple System Atrophy Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Multiple System Atrophy Therapeutics Market Share by Regions: 2020 VS 2027
Figure 16. Global Multiple System Atrophy Therapeutics Market Share by Regions (2022-2027)
Figure 17. Global Multiple System Atrophy Therapeutics Market Share by Players in 2020
Figure 18. Global Top Multiple System Atrophy Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Multiple System Atrophy Therapeutics as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Multiple System Atrophy Therapeutics Revenue in 2020
Figure 20. Global Multiple System Atrophy Therapeutics Revenue Market Share by Type (2016-2021)
Figure 21. Global Multiple System Atrophy Therapeutics Revenue Market Share by Type (2022-2027)
Figure 22. North America Multiple System Atrophy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Multiple System Atrophy Therapeutics Market Share by Type (2016-2027)
Figure 24. North America Multiple System Atrophy Therapeutics Market Share by Application (2016-2027)
Figure 25. North America Multiple System Atrophy Therapeutics Market Share by Country (2016-2027)
Figure 26. United States Multiple System Atrophy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Multiple System Atrophy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Multiple System Atrophy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Multiple System Atrophy Therapeutics Market Share by Type (2016-2027)
Figure 30. Europe Multiple System Atrophy Therapeutics Market Share by Application (2016-2027)
Figure 31. Europe Multiple System Atrophy Therapeutics Market Share by Country (2016-2027)
Figure 32. Germany Multiple System Atrophy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Multiple System Atrophy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Multiple System Atrophy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Multiple System Atrophy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Multiple System Atrophy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Multiple System Atrophy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Multiple System Atrophy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Multiple System Atrophy Therapeutics Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Multiple System Atrophy Therapeutics Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Multiple System Atrophy Therapeutics Market Share by Region (2016-2027)
Figure 42. China Multiple System Atrophy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Multiple System Atrophy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Multiple System Atrophy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Multiple System Atrophy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Multiple System Atrophy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Multiple System Atrophy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Multiple System Atrophy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Multiple System Atrophy Therapeutics Market Share by Type (2016-2027)
Figure 50. Latin America Multiple System Atrophy Therapeutics Market Share by Application (2016-2027)
Figure 51. Latin America Multiple System Atrophy Therapeutics Market Share by Country (2016-2027)
Figure 52. Mexico Multiple System Atrophy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Multiple System Atrophy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Multiple System Atrophy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Multiple System Atrophy Therapeutics Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Multiple System Atrophy Therapeutics Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Multiple System Atrophy Therapeutics Market Share by Country (2016-2027)
Figure 58. Turkey Multiple System Atrophy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Multiple System Atrophy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Multiple System Atrophy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. AFFiRiS AG Revenue Growth Rate in Multiple System Atrophy Therapeutics Business (2016-2021)
Figure 62. AstraZeneca Plc Revenue Growth Rate in Multiple System Atrophy Therapeutics Business (2016-2021)
Figure 63. Corestem Inc Revenue Growth Rate in Multiple System Atrophy Therapeutics Business (2016-2021)
Figure 64. MitoDys Therapeutics Ltd Revenue Growth Rate in Multiple System Atrophy Therapeutics Business (2016-2021)
Figure 65. Modag GmbH Revenue Growth Rate in Multiple System Atrophy Therapeutics Business (2016-2021)
Figure 66. Neuropore Therapies Inc Revenue Growth Rate in Multiple System Atrophy Therapeutics Business (2016-2021)
Figure 67. Prana Biotechnology Ltd Revenue Growth Rate in Multiple System Atrophy Therapeutics Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

---